Showing 7 posts of 52 posts found.

Semi-synthetic shortcut could boost supply of antimalarial

July 15, 2010
Manufacturing and Production malaria

US researchers are pushing forward with the development of a cheaper, semi-synthetic version of artemisinin, the basis of the most …

Blog footer

Digital Pharma: Playing healthcare games

June 23, 2010
Medical Communications Boehringer, Novartis, diabetes, digi game, malaria, virtual games

Boehringer Ingelheim has become the latest pharma company to use an online game to raise disease awareness. The pharma company …

Crucell malaria vaccine starts trials in Africa

May 11, 2010
Research and Development Crucell, malaria

Dutch biopharma firm Crucell has started a phase I trial of its AdVac-based malaria vaccine in Burkina Faso, West Africa. …

GSK and Crucell to develop malaria vaccine

April 7, 2010
Sales and Marketing Crucell, GSK, malaria

GlaxoSmithKline Biologicals and Dutch vaccines company Crucell are to develop a ‘second generation’ malaria vaccine candidate. Malaria causes 900,000 deaths …

Methylene blue poised to move into the clinic

February 24, 2010
Manufacturing and Production, Research and Development Novasep, ProveBlue, Provepharm, malaria

A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …

GSK launches ‘Open Lab’ to share resources

January 21, 2010
Research and Development, Sales and Marketing Africa, GlaxoSmithKline, malaria

GlaxoSmithKline has announced a series of measures to help improve medical treatment in poor countries. It has set up an …

Roche's cancer testing answers website

Digital Pharma: Byte-sized roundup

January 15, 2010
Medical Communications Diagnostics, Novartis, Roche, digital pharma, malaria

In this week’s roundup: Roche answers cancer testing questions, Novartis uses SMS in fight against malaria, UCB goes to Facebook …

Latest content